Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.
about
Interventions for metabolic bone disease in children with chronic kidney diseaseVitamin D compounds for people with chronic kidney disease requiring dialysisInterventions for bone disease in children with chronic kidney disease1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function.The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium.Value of the new bone classification system in pediatric renal osteodystrophy.Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysisReport of an NIH task force on research priorities in chronic kidney disease in children.Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease.Emerging drugs for hyperphosphatemia.Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.Role of bone biopsy in stages 3 to 4 chronic kidney disease.Mineral and bone disorders in children with chronic kidney disease.Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review.Defective skeletal mineralization in pediatric CKD.Management of secondary hyperparathyroidism: how and why?Roxarsone induces angiogenesis via PI3K/Akt signaling.Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure.Is there a practical role for bone biopsy in chronic kidney disease?Intraperitoneal Calcitriol for Treatment of Severe Hyperparathyroidism in Children with Chronic Kidney Disease: A Therapy Forgotten.
P2860
Q24187788-7EF257BB-FB9D-4212-9DCE-16B381D613B8Q24240582-24172160-FDD7-4B0E-BC47-E88869EB4819Q24240712-479A26E0-6678-40D4-B30C-8CD064645A32Q33939559-91FACA0A-E7B8-4800-842D-E44B0FB51B88Q33984825-58F1E51A-2F93-4CD6-B9AE-E8EF039EB017Q34118018-6FE9D5F8-7C16-4967-BA57-F0ECC005E5D5Q34281410-D61EFF0E-77A2-4EF0-9C3F-465D1CF8CE38Q35245052-68E071DC-E7BE-4011-AA63-C951BFB4EBB9Q35826159-E8B3566A-2836-496D-9067-0AC6436DF898Q36298407-50779674-5BD7-4C9D-B9E6-30E70081CCB8Q36666085-CB4BAB04-8F13-4C2D-883B-4D12C225A306Q36944004-ADDF3D62-9C56-4299-B5A1-A597EFC5C0A8Q37106569-49735E6C-2ABA-416B-A9E3-A09FD8465437Q37319136-657CADD5-A29B-4FBA-B77D-FE98D7FE4E20Q37938689-17E43B4F-5BBD-4554-A14A-18624602433BQ38079128-46F67930-5000-4DB6-A7E1-38FF1A96D97CQ38228157-6B0274B1-D6A0-42E5-9D58-EC9AEBFBC7FEQ38339007-C05CB453-4EE7-497A-9E32-854D2F1B5ED1Q38775426-D907DE3A-8678-4CF3-92A9-9E34F7E338DAQ40515450-3804330D-4753-4037-AF39-DAEB1E21B3A8Q46792106-6EF3D113-BE9D-41AE-B6A9-E931350E0BE4Q50711763-40827559-88B5-45FB-ABC4-7947F8F77DC8Q53759443-4BD06063-48B0-434C-98A3-42E5F787950B
P2860
Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Intermittent calcitriol therap ...... ntraperitoneal administration.
@en
Intermittent calcitriol therap ...... ntraperitoneal administration.
@nl
type
label
Intermittent calcitriol therap ...... ntraperitoneal administration.
@en
Intermittent calcitriol therap ...... ntraperitoneal administration.
@nl
prefLabel
Intermittent calcitriol therap ...... ntraperitoneal administration.
@en
Intermittent calcitriol therap ...... ntraperitoneal administration.
@nl
P2093
P1433
P1476
Intermittent calcitriol therap ...... ntraperitoneal administration.
@en
P2093
Goodman WG
Ramirez JA
Salusky IB
P304
P356
10.1046/J.1523-1755.1998.00045.X
P407
P577
1998-09-01T00:00:00Z
P5875
P6179
1011423497